VentriPoint Diagnostics Ltd. (VPT.V)
CAD 0.1
(11.11%)
CAD 0.1
(11.11%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -1.01 Million CAD | 78.42% |
| 2022 | -4.72 Million CAD | 48.11% |
| 2021 | -9.1 Million CAD | -1179.47% |
| 2020 | 843.84 Thousand CAD | -24.07% |
| 2019 | 1.11 Million CAD | 1769.64% |
| 2018 | -66.56 Thousand CAD | 95.1% |
| 2017 | -1.35 Million CAD | -434.84% |
| 2016 | 405.84 Thousand CAD | 129.45% |
| 2015 | -1.37 Million CAD | -308.98% |
| 2014 | 659.51 Thousand CAD | -59.23% |
| 2013 | 1.61 Million CAD | 80.01% |
| 2012 | 898.64 Thousand CAD | 1477.94% |
| 2011 | -65.21 Thousand CAD | -123.96% |
| 2010 | 272.18 Thousand CAD | -85.95% |
| 2009 | 1.93 Million CAD | 162.8% |
| 2008 | 737.12 Thousand CAD | 182.8% |
| 2007 | -890.22 Thousand CAD | -9124.0% |
| 2006 | -9651.17 CAD | 98.61% |
| 2005 | -696.12 Thousand CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -113.77 Thousand CAD | 88.85% |
| 2024 Q2 | 803.04 Thousand CAD | 892.76% |
| 2023 Q4 | -1.01 Million CAD | 45.6% |
| 2023 Q1 | -3.81 Million CAD | 19.26% |
| 2023 Q3 | -1.87 Million CAD | 34.64% |
| 2023 Q2 | -2.86 Million CAD | 24.83% |
| 2023 FY | -1.01 Million CAD | 78.42% |
| 2022 Q3 | -6.07 Million CAD | 14.97% |
| 2022 Q1 | -8.17 Million CAD | 10.24% |
| 2022 Q2 | -7.14 Million CAD | 12.66% |
| 2022 FY | -4.72 Million CAD | 48.11% |
| 2022 Q4 | -4.72 Million CAD | 22.15% |
| 2021 Q3 | -2.85 Million CAD | 12.31% |
| 2021 Q4 | -9.1 Million CAD | -219.15% |
| 2021 Q2 | -3.25 Million CAD | -38.76% |
| 2021 Q1 | -2.34 Million CAD | -377.97% |
| 2021 FY | -9.1 Million CAD | -1179.47% |
| 2020 FY | 843.84 Thousand CAD | -24.07% |
| 2020 Q2 | 1.24 Million CAD | 29.93% |
| 2020 Q1 | 961.86 Thousand CAD | -13.46% |
| 2020 Q3 | 685.7 Thousand CAD | -45.13% |
| 2020 Q4 | 843.84 Thousand CAD | 23.06% |
| 2019 Q3 | 672.08 Thousand CAD | -0.23% |
| 2019 FY | 1.11 Million CAD | 1769.64% |
| 2019 Q1 | 275.47 Thousand CAD | 513.83% |
| 2019 Q2 | 673.66 Thousand CAD | 144.55% |
| 2019 Q4 | 1.11 Million CAD | 65.37% |
| 2018 Q2 | -552.04 Thousand CAD | 40.82% |
| 2018 FY | -66.56 Thousand CAD | 95.1% |
| 2018 Q1 | -932.8 Thousand CAD | 31.36% |
| 2018 Q3 | -651.03 Thousand CAD | -17.93% |
| 2018 Q4 | -66.56 Thousand CAD | 89.78% |
| 2017 Q2 | -3.01 Million CAD | 11.23% |
| 2017 Q4 | -1.35 Million CAD | 40.01% |
| 2017 FY | -1.35 Million CAD | -434.84% |
| 2017 Q1 | -3.39 Million CAD | -935.51% |
| 2017 Q3 | -2.26 Million CAD | 24.74% |
| 2016 Q1 | -443.5 Thousand CAD | 67.82% |
| 2016 FY | 405.84 Thousand CAD | 129.45% |
| 2016 Q4 | 405.84 Thousand CAD | -22.81% |
| 2016 Q3 | 525.73 Thousand CAD | 132.74% |
| 2016 Q2 | 225.88 Thousand CAD | 150.93% |
| 2015 Q2 | 786.06 Thousand CAD | -17.28% |
| 2015 FY | -1.37 Million CAD | -308.98% |
| 2015 Q1 | 950.24 Thousand CAD | 44.08% |
| 2015 Q4 | -1.37 Million CAD | 20.11% |
| 2015 Q3 | -1.72 Million CAD | -319.48% |
| 2014 Q3 | 338.31 Thousand CAD | 2425.16% |
| 2014 FY | 659.51 Thousand CAD | -59.23% |
| 2014 Q4 | 659.51 Thousand CAD | 94.94% |
| 2014 Q2 | -14.55 Thousand CAD | -100.77% |
| 2014 Q1 | 1.88 Million CAD | 16.5% |
| 2013 Q1 | 1.06 Million CAD | 17.96% |
| 2013 FY | 1.61 Million CAD | 80.01% |
| 2013 Q3 | 1.77 Million CAD | 27.76% |
| 2013 Q4 | 1.61 Million CAD | -8.77% |
| 2013 Q2 | 1.38 Million CAD | 30.94% |
| 2012 FY | 898.64 Thousand CAD | 1477.94% |
| 2012 Q1 | 609.35 Thousand CAD | 1034.36% |
| 2012 Q2 | -934.63 Thousand CAD | -253.38% |
| 2012 Q3 | -64.19 Thousand CAD | 93.13% |
| 2012 Q4 | 898.64 Thousand CAD | 1499.77% |
| 2011 Q1 | 860.12 Thousand CAD | 216.01% |
| 2011 FY | -65.21 Thousand CAD | -123.96% |
| 2011 Q4 | -65.21 Thousand CAD | 87.42% |
| 2011 Q3 | -518.25 Thousand CAD | -178.29% |
| 2011 Q2 | 661.99 Thousand CAD | -23.04% |
| 2010 Q2 | 1.25 Million CAD | -14.27% |
| 2010 Q4 | 272.18 Thousand CAD | -85.0% |
| 2010 FY | 272.18 Thousand CAD | -85.95% |
| 2010 Q1 | 1.46 Million CAD | -24.42% |
| 2010 Q3 | 1.81 Million CAD | 44.54% |
| 2009 FY | 1.93 Million CAD | 162.8% |
| 2009 Q2 | 1.87 Million CAD | 47.7% |
| 2009 Q1 | 1.27 Million CAD | 72.67% |
| 2009 Q4 | 1.93 Million CAD | 3.22% |
| 2009 Q3 | 1.87 Million CAD | -0.17% |
| 2008 Q3 | -65.93 Thousand CAD | 83.63% |
| 2008 Q4 | 737.12 Thousand CAD | 1218.01% |
| 2008 FY | 737.12 Thousand CAD | 182.8% |
| 2008 Q1 | -472.28 Thousand CAD | 46.95% |
| 2008 Q2 | -402.77 Thousand CAD | 14.72% |
| 2007 FY | -890.22 Thousand CAD | -9124.0% |
| 2007 Q2 | -1775.59 CAD | 42.31% |
| 2007 Q3 | -1.47 Million CAD | -83221.0% |
| 2007 Q4 | -890.22 Thousand CAD | 39.83% |
| 2007 Q1 | -3077.80 CAD | 68.11% |
| 2006 Q3 | -677.88 Thousand CAD | 0.64% |
| 2006 Q4 | -9651.17 CAD | 98.58% |
| 2006 FY | -9651.17 CAD | 98.61% |
| 2006 Q1 | -685.81 Thousand CAD | 0.0% |
| 2006 Q2 | -682.21 Thousand CAD | 0.52% |
| 2005 FY | -696.12 Thousand CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Perimeter Medical Imaging AI, Inc. | -18.17 Million CAD | 94.39% |
| Therma Bright Inc. | -91.84 Thousand CAD | -1010.508% |
| Theralase Technologies Inc. | 342.96 Thousand CAD | 397.394% |